Top

Published in:

01-11-2020 | Hydrocephalus | Original Article - Neurosurgery general

The 30-day readmission rate in neurosurgery—a useful indicator for quality assessment?

Authors: Stephanie Schipmann, Eric Suero Molina, Julia Windheuser, Justin Doods, Michael Schwake, Eike Wilbers, Samer Zawy Alsofy, Nils Warneke, Walter Stummer

Published in: Acta Neurochirurgica | Issue 11/2020

Abstract

Background

A shift in how we evaluate healthcare outcomes has driven the introduction of quality indicators as potential parameters to evaluate value-based healthcare delivery. So far, only few studies have been performed evaluating quality indicators in the context of neurosurgery, especially in the European region. The purpose of this study was to evaluate the 30-day readmission rate, identify reasons for readmission regarding the various neurosurgical diagnoses, and discuss the usefulness of this rate as a potential quality indicator.

Methods

During a 6-year period, a total of 8878 hospitalized patients in our neurosurgical department were retrospectively analyzed and included in this study. Reasons for readmission were identified. Patients’ diagnoses and baseline characteristics were obtained in order to identify possible risk factors for readmission.

Results

The 30-day readmission rate was 2.9%. The most common reason for unplanned readmissions were surgical site infections. The reasons for readmissions varied significantly between the different underlying neurosurgical diseases (p < 0.001). Multivariate logistic regression revealed hydrocephalus (OR, 4) and shorter length of stay during index admission (OR, 0.9) as risk factors for readmission.

Conclusions

We provided an analysis of reasons for readmission for various neurosurgical diseases in a large patient spectrum in Germany. Although readmission rates are easy to track and an attractive tool for quality assessment, the rate alone cannot be seen as an adequate measure for quality in neurosurgery as it lacks a homogenous definition and depends on the underlying health care system. In addition, strategies for risk adjustment are required.

Abu-Bonsrah N, Goodwin CR, De la Garza-Ramos R, Sankey EW, Liu A, Kosztowski T, Elder BD, Bettegowda C, Bydon A, Witham TF, Wolinsky JP, Gokaslan ZL, Sciubba DM (2017) Readmissions after surgical resection of metastatic tumors of the spine at a single institution. World Neurosurg 101(695–701):e691. https://doi.org/10.1016/j.wneu.2017.02.065CrossRef

Al-Tamimi YZ, Sinha P, Chumas PD, Crimmins D, Drake J, Kestle J, British Pediatric Neurosurgery Group Audit C, Hayward R, Solanki GA, Thomson S, Thorne J (2014) Ventriculoperitoneal shunt 30-day failure rate: a retrospective international cohort study. Neurosurgery 74:29–34. https://doi.org/10.1227/NEU.0000000000000196CrossRefPubMed

Ansari SF, Yan H, Zou J, Worth RM, Barbaro NM (2018) Hospital length of stay and readmission rate for neurosurgical patients. Neurosurgery 82:173–181. https://doi.org/10.1093/neuros/nyx160CrossRefPubMed

Berenson RA, Paulus RA, Kalman NS (2012) Medicare’s readmissions-reduction program—a positive alternative. N Engl J Med 366:1364–1366. https://doi.org/10.1056/NEJMp1201268CrossRefPubMed

Buchanan CC, Hernandez EA, Anderson JM, Dye JA, Leung M, Buxey F, Bergsneider M, Afsar-Manesh N, Pouratian N, Martin NA (2014) Analysis of 30-day readmissions among neurosurgical patients: surgical complication avoidance as key to quality improvement. J Neurosurg 121:170–175. https://doi.org/10.3171/2014.4.JNS13944CrossRefPubMed

Carey K, Stefos T, Shibei Z, Borzecki AM, Rosen AK (2011) Excess costs attributable to postoperative complications. Med Care Res Rev 68:490–503. https://doi.org/10.1177/1077558710396378CrossRefPubMed

Chotai S, Guidry BS, Chan EW, Sborov KD, Gannon S, Shannon C, Bonfield CM, Wellons JC 3rd, Naftel RP (2017) Unplanned readmission within 90 days after pediatric neurosurgery. J Neurosurg Pediatr 20:542–548. https://doi.org/10.3171/2017.6.PEDS17117CrossRefPubMed

Cote DJ, Dasenbrock HH, Muskens IS, Broekman MLD, Zaidi HA, Dunn IF, Smith TR, Laws ER Jr (2017) Readmission and other adverse events after transsphenoidal surgery: prevalence, timing, and predictive factors. J Am Coll Surg 224:971–979. https://doi.org/10.1016/j.jamcollsurg.2017.02.015CrossRef

Cusimano MD, Pshonyak I, Lee MY, Ilie G (2017) A systematic review of 30-day readmission after cranial neurosurgery. J Neurosurg 127:342–352. https://doi.org/10.3171/2016.7.JNS152226CrossRefPubMed

10.

Dasenbrock HH, Angriman F, Smith TR, Gormley WB, Frerichs KU, Aziz-Sultan MA, Du R (2017) Readmission after aneurysmal subarachnoid hemorrhage: a nationwide readmission database analysis. Stroke 48:2383–2390. https://doi.org/10.1161/STROKEAHA.117.016702CrossRefPubMed

11.

Dasenbrock HH, Yan SC, Smith TR, Valdes PA, Gormley WB, Claus EB, Dunn IF (2017) Readmission after craniotomy for tumor: a National Surgical Quality Improvement Program Analysis. Neurosurgery 80:551–562. https://doi.org/10.1093/neuros/nyw062CrossRefPubMed

12.

Dharmarajan K, Hsieh AF, Lin Z, Bueno H, Ross JS, Horwitz LI, Barreto-Filho JA, Kim N, Bernheim SM, Suter LG, Drye EE, Krumholz HM (2013) Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA 309:355–363. https://doi.org/10.1001/jama.2012.216476CrossRefPubMedPubMedCentral

13.

Dickinson H, Carico C, Nuno M, Mukherjee D, Ortega A, Black KL, Patil CG (2015) Unplanned readmissions and survival following brain tumor surgery. J Neurosurg 122:61–68. https://doi.org/10.3171/2014.8.JNS1498CrossRefPubMed

14.

Donoho DA, Wen T, Babadjouni RM, Schwartzman W, Buchanan IA, Cen SY, Zada G, Mack WJ, Attenello FJ (2018) Predictors of 30- and 90-day readmission following craniotomy for malignant brain tumors: analysis of nationwide data. J Neuro-Oncol 136:87–94. https://doi.org/10.1007/s11060-017-2625-3CrossRef

15.

Elsamadicy AA, Sergesketter A, Ren X, Mohammed Qasim Hussaini S, Laarakker A, Rahimpour S, Ejikeme T, Yang S, Pagadala P, Parente B, Xie J, Lad SP (2018) Drivers and risk factors of unplanned 30-day readmission following spinal cord stimulator implantation. Neuromodulation 21:87–92. https://doi.org/10.1111/ner.12689CrossRefPubMed

16.

Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, Peterson ED, Curtis LH (2010) Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA 303:1716–1722. https://doi.org/10.1001/jama.2010.533CrossRefPubMed

17.

Kassin MT, Owen RM, Perez SD, Leeds I, Cox JC, Schnier K, Sadiraj V, Sweeney JF (2012) Risk factors for 30-day hospital readmission among general surgery patients. J Am Coll Surg 215:322–330. https://doi.org/10.1016/j.jamcollsurg.2012.05.024CrossRefPubMedPubMedCentral

18.

Marcus LP, McCutcheon BA, Noorbakhsh A, Parina RP, Gonda DD, Chen C, Chang DC, Carter BS (2014) Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010). J Neurosurg 120:1201–1211. https://doi.org/10.3171/2014.1.JNS131264CrossRefPubMed

19.

McGirt MJ, Leveque JC, Wellons JC 3rd, Villavicencio AT, Hopkins JS, Fuchs HE, George TM (2002) Cerebrospinal fluid shunt survival and etiology of failures: a seven-year institutional experience. Pediatr Neurosurg 36:248–255. https://doi.org/10.1159/000058428CrossRefPubMed

20.

Moghavem N, Morrison D, Ratliff JK, Hernandez-Boussard T (2015) Cranial neurosurgical 30-day readmissions by clinical indication. J Neurosurg 123:189–197. https://doi.org/10.3171/2014.12.JNS14447CrossRefPubMed

21.

Nuno M, Ly D, Ortega A, Sarmiento JM, Mukherjee D, Black KL, Patil CG (2014) Does 30-day readmission affect long-term outcome among glioblastoma patients? Neurosurgery 74:196–204; discussion 204-195. https://doi.org/10.1227/NEU.0000000000000243CrossRefPubMed

22.

Rambachan A, Smith TR, Saha S, Eskandari MK, Bendok BR, Kim JY (2014) Reasons for readmission after carotid endarterectomy. World Neurosurg 82:e771–e776. https://doi.org/10.1016/j.wneu.2013.08.020CrossRefPubMed

23.

Sarda S, Bookland M, Chu J, Shoja MM, Miller MP, Reisner SB, Yun PH, Chern JJ (2014) Return to system within 30 days of discharge following pediatric non-shunt surgery. J Neurosurg Pediatr 14:654–661. https://doi.org/10.3171/2014.8.PEDS14109CrossRefPubMed

24.

Schipmann S, Schwake M, Suero Molina E, Roeder N, Steudel WI, Warneke N, Stummer W (2017) Quality indicators in cranial neurosurgery: which are presently substantiated? A systematic review. World Neurosurg 104:104–112. https://doi.org/10.1016/j.wneu.2017.03.111CrossRefPubMed

25.

Schneider EB, Hyder O, Brooke BS, Efron J, Cameron JL, Edil BH, Schulick RD, Choti MA, Wolfgang CL, Pawlik TM (2012) Patient readmission and mortality after colorectal surgery for colon cancer: impact of length of stay relative to other clinical factors. J Am Coll Surg 214:390–398; discussion 398-399. https://doi.org/10.1016/j.jamcollsurg.2011.12.025CrossRefPubMed

26.

Shah MN, Stoev IT, Sanford DE, Gao F, Santiago P, Jaques DP, Dacey RG Jr (2013) Are readmission rates on a neurosurgical service indicators of quality of care? J Neurosurg 119:1043–1049. https://doi.org/10.3171/2013.3.JNS121769CrossRefPubMedPubMedCentral

27.

Singh S, Sparapani R, Wang MC (2018) Variations in 30-day readmissions and length of stay among spine surgeons: a national study of elective spine surgery among US Medicare beneficiaries. J Neurosurg Spine:1–6. https://doi.org/10.3171/2018.1.SPINE171064

28.

Taylor BE, Youngerman BE, Goldstein H, Kabat DH, Appelboom G, Gold WE, Connolly ES Jr (2016) Causes and timing of unplanned early readmission after neurosurgery. Neurosurgery 79:356–369. https://doi.org/10.1227/NEU.0000000000001110CrossRefPubMed

29.

Tsai TC, Joynt KE, Orav EJ, Gawande AA, Jha AK (2013) Variation in surgical-readmission rates and quality of hospital care. N Engl J Med 369:1134–1142. https://doi.org/10.1056/NEJMsa1303118CrossRefPubMedPubMedCentral

30.

Vaziri S, Cox JB, Friedman WA (2014) Readmissions in neurosurgery: a qualitative inquiry. World Neurosurg 82:376–379. https://doi.org/10.1016/j.wneu.2014.02.028CrossRefPubMed

31.

Wrubel DM, Riemenschneider KJ, Braender C, Miller BA, Hirsh DA, Reisner A, Boydston W, Brahma B, Chern JJ (2014) Return to system within 30 days of pediatric neurosurgery. J Neurosurg Pediatr 13:216–221. https://doi.org/10.3171/2013.10.PEDS13248CrossRefPubMed

Title: The 30-day readmission rate in neurosurgery—a useful indicator for quality assessment?
Authors: Stephanie Schipmann
Eric Suero Molina
Julia Windheuser
Justin Doods
Michael Schwake
Eike Wilbers
Samer Zawy Alsofy
Nils Warneke
Walter Stummer
Publication date: 01-11-2020
Publisher: Springer Vienna
Keywords: Hydrocephalus
Hydrocephalus
Hydrocephalus
Published in: Acta Neurochirurgica / Issue 11/2020
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-020-04382-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The 30-day readmission rate in neurosurgery—a useful indicator for quality assessment?

Abstract

Background

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 11/2020

Intensive care of traumatic brain injury and aneurysmal subarachnoid hemorrhage in Helsinki during the Covid-19 pandemic

Flat-shaped posterior cranial fossa was associated with poor outcomes of microvascular decompression for primary hemifacial spasm

Burr hole trepanation and insertion of a subperiosteal drain for chronic subdural haematoma: how I do it

Long-term prognosis of preserved useful hearing after surgery in patients with vestibular schwannoma: a study of 91 cases

Navigation assisted tubular resection of lumbar osteoid osteoma: how I do it

Chiari malformation type I and basilar invagination originating from atlantoaxial instability: a literature review and critical analysis